Funding, News and Announcements
» Go to news mainCombination therapies against cancer: New opportunities for translational research
TRANSCAN-3 is an international collaboration, comprised of 31 partners from 20 countries with a focus on supporting high-impact translational cancer research. Since 2021, CIHR has been a participating TRANSCAN-3 partner.
The main purpose of this call will be the design of patient preclinical models for combination therapies. Translational research using tumour samples collected from retrospective and/or prospective cohorts of patients.
Researchers from Canada are strongly encouraged to apply. Further instructions for applicants from Canadian institutions will be available on ResearchNet in Spring 2024.
Anticipated call launch date: April 26, 2024
Anticipated pre-proposals deadline: July 5, 2024
Anticipated full proposal deadline: November 29, 2024
For questions, contact the grants facilitator for your faculty.
Recent News
- Canada Foundation for Innovation
- Council of Atlantic Academic Libraries
- Operations & Maintenance Response Fund 2024
- Canada Foundation for Innovation
- Ireland Canada University Foundation: Craig Dobbin Legacy Scholarships
- United States Department of Defense new funding opportunities
- NordForsk‑led International Joint Initiative on Sustainable Development of the Arctic
- ACENET